Stewart A C, Gravitt P E, Cheng S, Wheeler C M
University of New Mexico Cancer Research and Treatment Center, Department of Cell Biology, Albuquerque 87131-5226, USA.
Genome Res. 1995 Aug;5(1):79-88. doi: 10.1101/gr.5.1.79.
Recently, several improvements of traditional PCR techniques have facilitated the amplification of significantly longer DNA target sequences. Here we report an improved method for amplification of entire human papillomavirus (HPV) genomes. Using rTth DNA polymerase, XL (Perkin-Elmer, Foster City CA), and the accompanying XL PCR buffer system, we have successfully amplified 8-kb genomes from approximately 10 copies of input reference strain HPV16 DNA. This long PCR (LPCR) method was subsequently used to amplify the entire HPV16 genome from clinical specimens. The fidelity with which the rTth DNA polymerase XL amplified target sequences under our chosen amplification conditions was estimated by partial sequencing of cloned LPCR products generated from cloned reference strain HPV16 genomes. A region spanning the HPV16 E6, E7, and part of the E1 open reading frames (ORFs) was sequenced in 29 clones. A total of 33 nucleotide substitutions were observed in the 23.5 kb sequenced. This corresponds to an error frequency of approximately one error per 700 bases. Finally, LPCR methods were used to amplify entire, novel HPV genomes from clinical specimens. LPCR primer pairs were designed for amplification of seven potentially novel HPV types. Amplicons of approximately 8 kb were generated from five of the seven HPV types targeted. One of the LPCR-generated novel genomes, CP141, was subsequently cloned and a partial sequence was determined.
最近,传统PCR技术的多项改进促进了更长DNA靶序列的扩增。在此,我们报告一种用于扩增整个人乳头瘤病毒(HPV)基因组的改进方法。使用rTth DNA聚合酶、XL(珀金埃尔默公司,加利福尼亚州福斯特城)及配套的XL PCR缓冲液系统,我们已成功从约10份输入的参考菌株HPV16 DNA拷贝中扩增出8 kb的基因组。随后,这种长PCR(LPCR)方法被用于从临床标本中扩增完整的HPV16基因组。通过对从克隆的参考菌株HPV16基因组产生的克隆LPCR产物进行部分测序,评估了在我们选定的扩增条件下rTth DNA聚合酶XL扩增靶序列的保真度。对29个克隆中跨越HPV16 E6、E7和部分E1开放阅读框(ORF)的区域进行了测序。在23.5 kb的测序区域中共观察到33个核苷酸替换。这相当于每700个碱基约有一个错误的频率。最后,LPCR方法被用于从临床标本中扩增完整的、新的HPV基因组。设计了LPCR引物对用于扩增7种潜在的新型HPV类型。在7种靶向的HPV类型中,有5种产生了约8 kb的扩增子。随后对LPCR产生的一种新型基因组CP141进行了克隆并测定了部分序列。